Article

LASIK tool helps manage ocular surface

Lafayette, LA—The LaFaci Surgical System (Vision Pro, LLC, Opelousas, LA) allows the LASIK surgeon to perform a number of specialized functions in the surgical field through the use of one handpiece. This capability, according to the developer of the system, Leon C. LaHaye II, MD, facilitates the entire second stage, i.e., following lifting of the flap, of the LASIK procedure.

"The LaFaci handpiece," he explained, "is placed on the patient's eye before lifting the flap, remains positioned until flap fixation is assured, and provides 11 specialized functions."

The introduction of this system is a departure from conventionally performed LASIK in that it standardizes the procedure, according to Dr. LaHaye, who has used this system on 119 eyes.

"Stage II begins the moment the corneal flap is reflected (incision exposure) and is completed with the corneal flap returned and sealed in its original position (incision closure)," he said.





"As an industry, LASIK surgeons have become very skilled in the management of diffuse lamellar keratitis, infectious keratitis, epithelial ingrowth, undercorrection, overcorrection, de-centered ablations, islands, flap striae, interface debris, plume dispersal, and other complications. Now we need to become more aggressive in prevention," Dr. LaHaye explained.



"In conventional LASIK, numerous techniques, methods, and instruments are used by LASIK surgeons to perform all aspects of the multitasked stage II. There is considerable variability and inconsistency in the performance of the numerous steps of stage II of conventional LASIK," Dr. LaHaye emphasized.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.